Optellum announces agreement with Bristol Myers Squibb to leverage AI to boost early lung cancer diagnosis
Optellum, a global leader in AI-driven clinical decision support for [...]
Tumour DNA in the blood can predict lung cancer outcome, study finds
A test to detect circulating tumour DNA can predict lung [...]
Lung cancer test predicts survival in early stages better than current methods
A test called ORACLE can predict lung cancer survival at [...]
Long-term conditions could delay lung cancer diagnosis
A new study reveals that patients living with certain long-term [...]
AI could predict risk of lung cancer at an earlier stage, study finds
Clinithink AI technology, capable of reading and understanding medical records, [...]
Inhalable sensors could enable earlier lung cancer detection
A new technology developed by researchers in the US could [...]
NHS ‘lung MOT’ trucks boost early diagnosis in deprived areas
Poorer people are now more likely to be diagnosed with [...]
Clinithink and AstraZeneca launch first-of-its-kind AI lung cancer project
Clinithink has partnered with AstraZeneca Oncology UK in a new [...]
The practical considerations of applying AI in healthcare settings
By Dr Johnathan Watkins, VP of Market Access and Clinical Research, Optellum
